- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 48.75M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $33M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $32M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.66M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.7M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $103.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $114.33M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $63.49M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $62.71M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $108.17M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $107.05M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $29.98M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $29.65M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $212.07M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $221.37M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 44.21M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $4.44M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.09M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $7.23M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.8M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.51M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.97M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.88M |